Slide 1: Slide 1
Slide 2: Update due to Covid-19
Update due to Covid-19 Dr Richard Hausmann, President and CEO – April 28, 2020
Slide 3: Important information
Important information This presentation includes forward-looking statements including, but not limited to, statements relating to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future event
Slide 4: The world has changed
The world has changed • The Covid-19 pandemic has severely impacted public life and business all over the world in an unprecedented way • Due to our particular FY (May-April), our usually strong last quarter was increasingly affected • As the pandemic escalated it impacted Europe and North America i
Slide 5: Highlights of impact from Covid-19
Highlights of impact from Covid-19 Impact on Strengthened Supply chains Changed whole quarter financial and production outlook for FY (Feb-April) position and continued to run 19/20 and on order, increased well under the withdrawn mid- revenue and available circumstances term scenario costs liquidit
Slide 6: Keep our employee safe
Keep our employee safe • As much as possible, we let our employees work from home and we are following local recommendations • All travel except business essential stopped • Production employees split into segregated shifts • Increased precaution: social distance, masks, increased hand hygiene • Pre
Slide 7: The "wave from East to West" leads to different timing and impact on markets globally
The ”wave from East to West” leads to different timing and impact on markets globally China Europe North America Middle East and Africa Public procurement and Increasing delays in Delays in installations, but Mainly green field tendering has re-started installations in most varies between states mar
Slide 8: Radiotherapy treatments continue at near normal levels during Covid-19
Radiotherapy treatments continue at near normal levels during Covid-19 Global treatment volumes1) as % of normal level 97% 100% 80% 60% 40% 20% 0% of normal global treatment volumes during week 16, starting April 13 3 4 5 6 7 8 9 10 11 12 13 14 15 16 weeks 2020 “Elekta will be here until cancer isn’
Slide 9: Secure our supply chain – operational under difficult circumstances
Secure our supply chain – operational under difficult circumstances Production sites/supply chain • Beijing, China – fully operational • Crawley, UK/Veenendaal, the Netherlands – ”essential business” status, normal production • Essential business status for suppliers and dual sourcing strategy helps
Slide 10: Advanced SW applications highly relevant in new situation
Advanced SW applications highly relevant in new situation • Updated MOSAIQ for Covid-19 support – quick guides to configure tasks and actions • Remote access to MOSAIQ, Monaco and ProKnow to work more effectively with less physical contact – supported by self-training, videos, weekly webinars • ProK
Slide 11: Strengthened liquidity and secured long term financing
Strengthened liquidity and secured long term financing 1) Net Debt /EBITDA and available cash Maturity profile SEK M SEK M 2,5 SEK 7 000 5000 ~6 bn 6 000 2,0 4000 5 000 1,5 4 000 3000 1,0 3 000 2000 2 000 0,5 1000 0.71 1 000 0,0 0 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4E 17/18 18/19 19/20 20/21 21/22
Slide 12: Changed outlook FY 19/20 and withdrawn mid-term scenario
Changed outlook FY 19/20 and withdrawn mid-term scenario New outlook Scenario FY 19/20 FY 20/21-22/23 Net sales ~1 percent due to ongoing uncertainties we withdraw mid-term scenario EBITA margin 16-17 percent Updated outlook will be published when we can further quantify the impact of Covid-19 on th
Slide 13: Recent highlights on order intake – Elekta Unity going strong
Recent highlights on order intake – Elekta Unity going strong st 7 th Dutch order of 1 Elekta Unity to RIF Latin American Leeuwarden together with order of Elekta Unity three Versa HD to San José Moscati Hospital together with 1 st Leksell Gamma Knife, Flexitron, Versa HD Japanese order and MOSAIQ o
Slide 14: Changing business environment due to Covid-19
Changing business environment due to Covid-19 • Elekta Digital – opportunities to continue developing more remote software products • New digital launch – Geneva (brachy therapy) • Digital order fulfillment allowing faster and better prepared installations in challenging countries 14
Slide 15: Summary
Summary • Covid-19 impacts our business in a serious way • We adapted our guidance for FY19/20 • Elekta manages the challenges in relation to safety of our people, customer support, liquidity and productivity in a proactive way • Productivity measures will be strengthened in the coming quarters • Un
Slide 16: Q & A
Q&A Dr Richard Hausmann, President and CEO Gustaf Salford, CFO